Our findings for MM were consistent with results from a previous meta-analysis of 10 studies (7 cohort, 3 case-control) reporting a borderline significant increased MM risk (HR = 1.22, 95% CI = 0.98 to 1.53) comparing participants with vs without a history of T2D. 11 The mechanisms linking T2D with lymphomagenesis are not fully understood.
← all excerpts
Type 2 diabetes and risk of non-Hodgkin lymphoma and multiple myeloma: a pooled analysis.
1
—
—